Eli Lilly and Company - Change In Other Working Capital

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-In-Other-Working-Capital" stands at -1.62 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2023, the lowest value since 03/31/2018.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -5.15 Billion United States Dollars compared to the value the year prior.
The 1 year change is -5.15 Billion United States Dollars.
The 3 year change is -8.20 Billion United States Dollars.
The 5 year change is -2.88 Billion United States Dollars.

The Serie's long term average value is 1.18 Billion United States Dollars. It's latest available value, on 09/30/2023, is -2.80 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2017, to it's latest available value, on 09/30/2023, is +4.20 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2020, to it's latest available value, on 09/30/2023, is -8.20 Billion.